非酒精性脂肪性肝病不同肝纤维化状态下的肝脏相关与心血管事件风险差异
Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-07-16
非酒精性脂肪性肝病(NAFLD)影响全球超过四分之一人口,常见死因包括心血管疾病、失代偿和肝细胞癌。临床上识别这些并发症风险仍存未满足需求,需依据肝纤维化状态评估肝脏相关与心血管事件的风险差异。
要点
- NAFLD影响全球超过四分之一人口,构成全球健康与经济负担
- NAFLD患者常见死因包括心血管疾病、失代偿和肝细胞癌
- 临床上识别NAFLD患者并发症风险仍为未满足需求
核心结论
- NAFLD患者常见死因包括心血管疾病、失代偿和肝细胞癌,但临床识别这些并发症风险仍为未满足需求。
主要发现
- NAFLD影响全球超过四分之一人口,已成为全球健康与经济负担。
- NAFLD患者常见死因包括心血管疾病、失代偿和肝细胞癌。
临床怎么用
- 临床实践中需关注NAFLD患者心血管疾病、失代偿和肝细胞癌等并发症风险的识别。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nonalcoholic fatty liver disease (NAFLD) has affected more than one-fourth of the global population, thus emerging as a worldwide health and economic burden.1 The common causes of death in patients with NAFLD include cardiovascular disease (CVD), decompensation, and hepatocellular carcinoma (HCC). However, identifying the risk of these complications in patients with NAFLD remains an unmet need in clinical practice.
来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。
引用
- Tamaki N, Higuchi M, Kurosaki M, et al. Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2021. PMID: 34280550. doi:10.1016/j.cgh.2021.07.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。